Summary
Guardant Health, Inc. (GH) filed an 8-K on May 6, 2022, to announce the resignation of Dr. Bahija Jallal from its Board of Directors. Her resignation will be effective at the Company's Annual Meeting of Stockholders on June 15, 2022. Dr. Jallal indicated that her departure is not due to any disagreement with the Company regarding its operations, policies, or practices. This is a routine personnel change, and investors should note that it does not appear to be linked to any underlying operational or financial issues within Guardant Health.
Key Highlights
- 1Dr. Bahija Jallal is resigning from the Guardant Health Board of Directors.
- 2The resignation will be effective on June 15, 2022, at the Company's Annual Meeting of Stockholders.
- 3Dr. Jallal stated her decision to resign is not related to any dispute or disagreement with the Company.
- 4This filing pertains to a director's departure, not an executive officer.
- 5The effective date of resignation is tied to the upcoming annual stockholder meeting.
Frequently Asked Questions
Dr. Bahija Jallal is resigning from the Board of Directors of Guardant Health, Inc.
The resignation will be effective on June 15, 2022, which is the date of the Company's next Annual Meeting of Stockholders.
No, Dr. Jallal informed the Company that her decision to resign was not a result of any dispute or disagreement with Guardant Health on any matter relating to its operations, policies, or practices.
This filing specifically concerns a director's resignation. It does not indicate any changes to the executive officers of Guardant Health.